EN DE
Watch Aino Health AB for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Aino Health AB (AINO) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Aino Health AB stock SEK 0.19, price SEK 0.20, that is 4.0% below the price, quality 44 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare SE · ISIN SE0009242555

AH Aino Health AB logo Thin data Nov 10, 2026

Aino Health AB

AINO · ST
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Fair value kr 0.1911 · Fairly valued
Quality 44/100
Negative equity (buybacks among others)
Revenue last quarter 10% below a year ago.
Weak Growth (revenue 5y +0.9 %/yr in SEK)
Loss-making · -41.6% net margin (TTM)
Negative free cash flow
Trails peers (2/7)
Narrow moat 8/100 · thin data
Thin data
Estimate⚠ Thinly traded
Watch Aino Health AB for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 1.21 kr 0.0820 Fair Value kr 0.1911 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range kr 0.0820 – kr 1.21 · fair‑value band kr 0.1433 – kr 0.2389 · the kr 0.1990 price screens above the kr 0.1911 fair value. As of Nov 10, 2026.

Follow Aino Health in your weekly email

Every Wednesday you see whether Aino Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Aino Health AB (publ) develops and provides digital SaaS platforms and consulting services focused on workplace health management and operational efficiency for organizations.

Show moreShow less

It offers HealthManager, a cloud-based system that supports company management in monitoring employee well-being, managing staff turnover, and reducing sick leave, while ensuring compliance with regulations such as GDPR. The company also provides ongoing consulting services for onboarding and implementation of HealthManager, as well as process optimization and preventive measures for workplace health.

It serves personnel managers, business leaders, and employees. The company was incorporated in 2016 and is based in Stockholm, Sweden.

Stock analysis

Aino Health AB (AINO) currently trades at kr 0.1990, while our estimate is kr 0.1911, so the stock looks roughly fairly valued today (gap 4.1%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: kr 0.1433 (bear) to kr 0.2389 (bull), the price of kr 0.1990 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Aino Health AB reported revenue of 26.1M SEK in FY2025 versus 23.0M SEK in FY2021, a compound +3.2%/yr. Reported net income was −6.1M SEK in FY2025.

Key figures

Market cap 40.7M SEK (≈ $4.1M) Micro · P/S ratio 1.74 · EPS (TTM) kr −0.0100 · Net margin −23.4% · Return on assets (EBIT) −75.2% (5-year average) · Operating margin −35.7% · Revenue (TTM) 23.5M SEK · Revenue growth (YoY) −10.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 19% below its 52-week high and 72% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −35% fair-value upside, at −4%, AINO screens cheaper than that median.

Fair Value

Bear kr 0.1433 Fair Value kr 0.1911 Bull kr 0.2389
Price kr 0.1990 · Downside -4.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 44/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 25
How much profit the company makes from its sales and capital
Quality Growth 69
Are margins and returns getting better?
Cashflow 25
Do the profits arrive as real cash?
Financial strength 39
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 66
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 57
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 5/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+9.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
Start year 2020 (pandemic). Over 10 years: +1.6% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−56.1% (2020) → −20.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch AINO, get fair value alerts →

Compare Aino Health AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks

Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside −4.0% · Above median
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −63.0% · Bottom 25%
Net margin (12 months) −41.6% · Bottom 25%
Operating margin (12 months) −35.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −10.3% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 1.73× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)28 · sector 13
FUTURE (revenue growth)0 · sector 45
PAST (return on equity)0 · sector 0
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 46

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $32.42 $36.16 +12% vs AINO
Veeva Systems Inc VEEV $305.55 $337.04 +10% vs AINO
HealthEquity, Inc HQY $103.54 $112.32 +8% vs AINO
Waystar Holding WAY $29.30 $29.10 −1% vs AINO
Tempus AI, Inc TEM $80.54 $52.58 −35% vs AINO
HeartFlow, Inc HTFL $55.80 $34.82 −38% vs AINO
Hinge Health, Inc HNGE $123.23 $51.25 −58% vs AINO
Pro Medicus Limited PME A$207.31 A$85.12 −59% vs AINO
BrightSpring Health Services, Inc BTSG $72.49 $25.72 −65% vs AINO
XtalPi Holdings 2228 HK$6.37 HK$1.53 −76% vs AINO

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Aino Health AB: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Aino Health AB Fair Value". https://www.fairvalue-calculator.com/stock/AINO

Frequently asked questions

Is Aino Health AB (AINO) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is kr 0.1911 versus a price of kr 0.1990, about 4% lower (fairly valued).
What is the fair value of AINO?
Our estimate for Aino Health AB is kr 0.1911 (as of Nov 10, 2026), built from audited fundamentals. The current price: kr 0.1990.
What is the quality score of AINO?
Aino Health AB has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aino Health AB (AINO)?
Our calculated price target is the estimate of kr 0.1911 (as of Nov 10, 2026). Cautious scenario kr 0.1433, optimistic scenario kr 0.2389. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Aino Health AB stock forecast for 2026?
Our estimate puts fair value at kr 0.1911, about 4% lower versus a price of kr 0.1990 (fairly valued). Cautious scenario kr 0.1433, optimistic scenario kr 0.2389. The calculation is refreshed regularly with new filings.
What is the revenue of Aino Health AB (AINO)?
Aino Health AB reported trailing-twelve-month revenue of about 23.5M SEK (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Aino Health AB (AINO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aino Health AB it is kr 0.1911 per share (as of Nov 10, 2026), against a price of kr 0.1990.
Is Aino Health AB stock overvalued or undervalued in 2026?
As of Nov 10, 2026, AINO trades above its calculated fair value: price kr 0.1990, fair value kr 0.1911, a gap of about −4% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AINO?
No. The price is what the market pays today (kr 0.1990); the fair value is what the company's own numbers justify (kr 0.1911). For Aino Health AB the two are kr 0.0079 per share apart. That gap is exactly why we show both numbers side by side.
How much is Aino Health AB worth?
The market values Aino Health AB at about 40.7M SEK (market capitalisation, as of Nov 10, 2026). Per share that is kr 0.1990; our models calculate a fair value of kr 0.1911 per share.
What do the bullish and bearish scenarios say about AINO?
Our models span a range for Aino Health AB: cautious scenario kr 0.1433, base kr 0.1911, optimistic kr 0.2389 per share (as of Nov 10, 2026, price kr 0.1990). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Aino Health AB (AINO)?
Balance-sheet figures for Aino Health AB (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is AINO from its 52-week high?
Aino Health AB trades at kr 0.1990, about 19% below its 52-week high of kr 0.2460 and 72% above the low of kr 0.1160 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.1911 is for.
Which stocks are comparable to Aino Health AB?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aino Health AB stock attractive at the current price?
The data as of Nov 10, 2026: price kr 0.1990, calculated fair value kr 0.1911 (−4%), Quality Score 44/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Aino Health AB itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aino Health AB (AINO)?
The closing price on Nov 10, 2026 was kr 0.1990. Our estimate is kr 0.1911, about 4% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aino Health AB right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Aino Health AB

How large is the market capitalisation of Aino Health AB (AINO)?
The market capitalisation of Aino Health AB is 40.7M SEK (≈ $4.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Aino Health AB (AINO)?
The price-to-sales ratio of Aino Health AB is 1.74 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Aino Health AB (AINO)?
Earnings per share at Aino Health AB are kr −0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Aino Health AB (AINO)?
The net margin of Aino Health AB is −23.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Aino Health AB (AINO)?
On an EBIT basis the return on assets of Aino Health AB is −75.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aino Health AB (AINO)?
The operating margin of Aino Health AB is −35.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aino Health AB (AINO)?
Revenue at Aino Health AB is growing −10.3% versus a year earlier (3y avg +9.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Aino Health AB (AINO) generate?
The free cash flow of Aino Health AB is −2.4M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Aino Health AB (AINO) carry?
The net debt of Aino Health AB is 2.5M SEK (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Aino Health AB in the live analysis

One click puts Aino Health AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.